Melissa Lassig‐Smith
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
- Pharmacology 13
- Antibiotics Pharmacokinetics and Efficacy 13
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- Janine Stuart (20 shared papers)Jeffrey Lipman (18 shared papers)Jason A. Roberts (13 shared papers)Andrew Alexander Udy (8 shared papers)Therese Starr (13 shared papers)Paul Max Jarrett (11 shared papers)Steven C. Wallis (11 shared papers)Robert James Boots (7 shared papers)
In The Last Decade
Melissa Lassig‐Smith
28 papers receiving 1.0k citations
Melissa Lassig‐Smith's Hit Papers
Peers
Comparison fields: 5 of 73
- Applied Microbiology and Biotechnology 106
- Pharmacology 506
- Molecular Medicine 146
- Nephrology 125
- Critical Care and Intensive Care Medicine 58
Countries citing papers authored by Melissa Lassig‐Smith
This map shows the geographic impact of Melissa Lassig‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Lassig‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Lassig‐Smith more than expected).
Fields of papers citing papers by Melissa Lassig‐Smith
This network shows the impact of papers produced by Melissa Lassig‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Lassig‐Smith. The network helps show where Melissa Lassig‐Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Melissa Lassig‐Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 110 | |
| 2 | 2010 | 108 | |
| 3 | Continuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis Hit paper breakdown → | 2024 | 88 |
| 4 | 2011 | 73 | |
| 5 | 2014 | 66 | |
| 6 | 2017 | 65 | |
| 7 | 2016 | 56 | |
| 8 | 2016 | 47 | |
| 9 | 2019 | 46 | |
| 10 | 2013 | 46 | |
| 11 | 2016 | 44 | |
| 12 | 2016 | 44 | |
| 13 | 2020 | 33 | |
| 14 | 2019 | 28 | |
| 15 | 2014 | 24 | |
| 16 | 2020 | 20 | |
| 17 | 2015 | 19 | |
| 18 | 2020 | 17 | |
| 19 | 2022 | 16 | |
| 20 | 2012 | 14 |
About Melissa Lassig‐Smith
Melissa Lassig‐Smith is a scholar working on Pharmacology, Molecular Medicine, Nephrology, Applied Microbiology and Biotechnology and Neurology, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Resistance in Bacteria (6 papers), Adrenal Hormones and Disorders (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (3 papers), Antibiotic Use and Resistance (3 papers), Acute Kidney Injury Research (3 papers), Pneumonia and Respiratory Infections (2 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (106 citations), Pharmacology (506 citations), Molecular Medicine (146 citations), Nephrology (125 citations) and Critical Care and Intensive Care Medicine (58 citations). Melissa Lassig‐Smith has collaborated with scholars based in Australia, France and Hong Kong. Frequent co-authors include Janine Stuart, Jeffrey Lipman, Jason A. Roberts, Andrew Alexander Udy, Therese Starr, Paul Max Jarrett, Steven C. Wallis, Robert James Boots, Renae Deans and Michael Stephen Roberts. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Intensive Care Medicine, BMC Infectious Diseases, JAMA and Anesthesia & Analgesia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.